Related Experiment Videos
HPV and p53 in urinary bladder carcinoma
G P Mincione1, L Messerini, C Saltutti
1Instituto di Anatomia e Isologia Patologica, Università di Firenze.
Pathologica
|June 1, 1994
Summary
Human papillomavirus (HPV) was studied in urothelial carcinoma cases. HPV type 31/33/51 was found in one case, correlating with p53 protein expression and suggesting a role in neoplasia pathogenesis.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Urothelial carcinoma is a significant malignancy.
- The role of viral infections, such as human papillomavirus (HPV), in cancer development is an area of ongoing research.
- The p53 tumor suppressor gene is frequently altered in various cancers, including urothelial carcinoma.
Purpose of the Study:
- To investigate the presence of HPV and its correlation with p53 protein expression in urothelial carcinoma.
- To explore the potential role of specific HPV types in the pathogenesis of urothelial carcinoma.
Main Methods:
- Analysis of 18 cases of urothelial carcinoma (grades 1, 2, and 3).
- Detection of HPV presence and specific HPV types (31/33/51).
- Assessment of p53 protein expression.
Main Results:
- One case of grade 2 urothelial papillary carcinoma infiltrating the lamina propria tested positive for HPV types 31/33/51.
- This same case also showed positive expression for the p53 protein.
- The presence of HPV was correlated with p53 protein expression in this specific instance.
Conclusions:
- The findings suggest a potential role for HPV type 31/33/51 in the pathogenesis of urothelial carcinoma.
- HPV infection may lead to alterations in the p53 gene, contributing to cancer development.
- Further research is warranted to elucidate the precise mechanisms of HPV involvement in urothelial carcinogenesis.